Argenx
ARGX
#536
Rank
C$64.64 B
Marketcap
C$1,045
Share price
-6.62%
Change (1 day)
16.89%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: C$64.64 Billion

As of February 2026 Argenx has a market cap of C$64.64 Billion. This makes Argenx the world's 536th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026C$64.64 B-10.29%
2025C$72.05 B34.09%
2024C$53.74 B79.55%
2023C$29.93 B5.25%
2022C$28.43 B21.34%
2021C$23.43 B31.09%
2020C$17.87 B99.01%
2019C$8.98 B88.1%
2018C$4.77 B89.48%
2017C$2.52 B
2014C$0.16 B

End of Day market cap according to different sources

On Feb 25th, 2026 the market cap of Argenx was reported to be:

C$68.22 Billion
by Nasdaq info icon info icon
C$69.20 Billion
by CompaniesMarketCap info icon info icon